• News
  • SAN DIEGO
  • BioTech

Mast Therapeutics begins phase 2 study of MST-188

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments

Mast Therapeutics Inc.

Company Website

12390 El Camino Real Ste., 150
San Diego, CA 92130

Company Trade Data

Stock Symbol Close
Change
Chg %Chg
Volume
52-Week
High Low
MSTX
0.47
  0.0  
+ 0.00%
716,164,000
0.69
0.4

Mast Therapeutics Inc. Executive(s):

Brian Culley

  • Chief Executive Officer

Patrick Keran

  • Chief Operating Officer, President

Brandi Roberts

  • Chief Financial Officer
Subscribe Today!